Investing.com - Merck reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.24 on revenue of €4.97B. Analysts polled by Investing.com anticipated EPS of €2.19 on revenue of €4.96B.
Merck shares are up 46% from the beginning of the year, still down 6.47% from its 52 week high of €219.40 set on November 5. They are outperforming the DAX which is up 17.23% from the start of the year.
Merck shares lost 100.00% in pre-market trade following the report.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings missed by Siemens Healthineers on November 4, who reported EPS of €0.53 on revenue of €5.16B, compared to forecasts EPS of €0.585 on revenue of €4.89B.
Bayer had beat expectations on Tuesday with third quarter EPS of €1.05 on revenue of €9.78B, compared to forecast for EPS of €0.8831 on revenue of €9.21B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar